Skip to content

Clinical evaluation and application of Anshen Dingzhi Recipe in the treatment of breast cancer induced post-traumatic stress disorder

Clinical evaluation and application of Anshen Dingzhi Recipe in the treatment of breast cancer induced post-traumatic stress disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077801
Enrollment
Unknown
Registered
2023-11-20
Start date
2022-11-21
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer due to post-traumatic stress disorder

Interventions

Treatment group:Anshen Dingzhi Fang+Paroxetine

Sponsors

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: a. All cases were confirmed as breast cancer by pathology or cytology, the stage criteria are patients below stage II, and all patients have been treated by surgery combined with radiotherapy or chemotherapy; B. PTSD symptoms were evaluated by PCL-C for at least 1 month, and the diagnosis of PTSD was confirmed by CAPS evaluation; C. KPS (Karnofsk) score>60, estimated survival>6 months; D. 18-70 years old, with education level above primary school; E. The patient's condition is stable, without severe center of gravity, liver, brain, kidney and other organic damage or bone marrow hematopoietic dysfunction; F. The patient has clear mind, no dyslexia and can complete the questionnaire; G. The patient can understand and agree to participate in this study and has good compliance.

Exclusion criteria

Exclusion criteria: A. Non primary breast cancer; B. Previous history of primary or secondary mental disorders, taking psychiatric drugs; C. Parents with mental disorders within three generations; D. Special psychotherapy (cognitive behavioral therapy focusing on trauma, eye movement desensitization and reprocessing); E. In addition to breast cancer, it is experiencing other major traumatic events; F. Breast cancer patients with brain metastasis; G. Pregnant women H. Participants in other clinical studies within the past month; I. According to the judgment of the researchers, there are other reasons that may lead to loss of follow-up or may not be suitable for selection.

Design outcomes

Primary

MeasureTime frame
Post-traumatic stress disorder diagnostic scale (CAPS);After trauma Self rating stress disorder scale (PCL-C);PCL-C scale reduction rate;

Secondary

MeasureTime frame
Quality of life scale for breast cancer patients (FACT-B);Breast PRO scale of traditional Chinese medicine after cancer surgery;Self-Rating Anxiety Scale;Self-Rating Depression Scale;Laboratory related indicators: blood inflammation related indicators, HPA axis related indicators, estrogen related indicators, immune related indicators;

Countries

China

Contacts

Public ContactZhu Yongfu

Department of Oncology, First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

zyf240@ahtcm.edu.cn+86 138 6671 0495

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026